These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9631992)

  • 81. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
    Lecha M
    Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
    Tausch I; Bräutigam M; Weidinger G; Jones TC
    Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
    Evans EG; Sigurgeirsson B
    BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Toenail fungus: drill to kill. Delivering antifungal medicine through holes in the infected nail may make it more effective.
    Harv Health Lett; 2007 Mar; 32(5):6. PubMed ID: 17390494
    [No Abstract]   [Full Text] [Related]  

  • 88. Combination of fluconazole and urea in a nail lacquer for treating onychomycosis.
    Baran R; Coquard F
    J Dermatolog Treat; 2005 Feb; 16(1):52-5. PubMed ID: 15897169
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical Inquiry: which oral antifungal works best for toenail onychomycosis?
    Volk B; Tiu A; St Anna L
    J Fam Pract; 2013 Feb; 62(2):100-1. PubMed ID: 23405380
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
    Piraccini BM; Sisti A; Tosti A
    J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.
    Zane LT; Plattner J; Chanda S; Coronado D; Merchant T; Alley MR; Gupta AK
    Drugs Today (Barc); 2015 Oct; 51(10):599-607. PubMed ID: 26583302
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S; Tsubouchi I; Okubo A
    J Dermatol; 2018 Oct; 45(10):1151-1159. PubMed ID: 30156314
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
    Cook-Bolden FE; Lin T
    Cutis; 2017 Apr; 99(4):286-289. PubMed ID: 28492600
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Two novel itraconazole pulse therapies for onychomycosis: a 2-year follow-up.
    Avner S; Nir N; Baruch K; Henri T
    J Dermatolog Treat; 2006; 17(2):117-20. PubMed ID: 16766337
    [TBL] [Abstract][Full Text] [Related]  

  • 95. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Plasma concentrations of fluconazole after a single oral dose and administration in drinking water in cockatiels (Nymphicus hollandicus).
    Ratzlaff K; Papich MG; Flammer K
    J Avian Med Surg; 2011 Mar; 25(1):23-31. PubMed ID: 21657184
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole.
    Haneke E; Tajerbashi M; De Doncker P; Heremans A
    Dermatology; 1998; 196(3):323-9. PubMed ID: 9621140
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Topical therapy for toenail onychomycosis: an evidence-based review.
    Gupta AK; Daigle D; Foley KA
    Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nail and Foot Procedures.
    Bailey J
    Prim Care; 2022 Mar; 49(1):63-83. PubMed ID: 35125159
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Investigation on utility of some novel terpenes on transungual delivery of fluconazole for the management of onychomycosis.
    Adin SN; Gupta I; Ali A; Aqil M; Mujeeb M; Sultana Y
    J Cosmet Dermatol; 2022 Oct; 21(10):5103-5110. PubMed ID: 35390220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.